GRMN (GRMN) investor files Form 144 to sell 2,485 NYSE shares of common stock
Rhea-AI Filing Summary
An investor filed a notice on Form 144 to sell 2,485 shares of common stock through UBS Financial Services, Inc. on or about December 16, 2025, with the shares listed on the NYSE. The filing reports an aggregate market value of $513,674.35 for the planned sale, compared with 192,334,806 shares outstanding for this class of stock.
The shares to be sold were acquired from the issuer on December 15, 2025 as part of a restricted stock unit (RSU) transaction, with the same date shown as the payment date and no indication of a gift. The notice also states that the seller represents not knowing any undisclosed material adverse information about the issuer’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
What does the GRMN Form 144 filing disclose?
The Form 144 filing for GRMN discloses a planned sale of 2,485 shares of common stock through UBS Financial Services, Inc. on the NYSE, with an aggregate market value of $513,674.35.
How many GRMN shares are planned for sale and what is their market value?
The notice covers the proposed sale of 2,485 shares of common stock with an aggregate market value of $513,674.35, as stated in the securities information section.
When and how were the GRMN shares to be sold acquired?
The shares to be sold were acquired on December 15, 2025 in an RSU (restricted stock unit) transaction from the issuer, with the same date listed as the payment date.
On which exchange and through which broker will the GRMN shares be sold?
The filing lists UBS Financial Services, Inc. as the broker, with the shares to be sold on the NYSE.
How many GRMN shares of this class are outstanding?
The Form 144 indicates that there are 192,334,806 shares of this class of common stock outstanding.
Does the GRMN Form 144 include any representation about undisclosed information?
Yes. The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.